From NVIDIA: 2025-06-11 06:55:00

At NVIDIA GTC Paris, European healthcare and life sciences companies showcase AI-driven impact to address staffing shortages and rising costs. They utilize NVIDIA Inception program for startups and platforms like NVIDIA BioNeMo and DGX Cloud to drive better health outcomes in the region and beyond.

London-based Inception startup Basecamp Research unveils BaseData, the world’s largest biological dataset for generative AI in life sciences. The dataset contains over 9.8 billion new biological sequences and is 30x faster than existing databases. Basecamp collaborates with NVIDIA to accelerate drug discovery and unlock biological design breakthroughs.

Guy’s and St. Thomas’ NHS Foundation Trust in the UK launches PATH initiative with General Catalyst and Inception startups Hippocratic AI and Sword Health. PATH integrates AI agents to reduce specialty care waitlists and improve pain management, aiming for better healthcare delivery and personalized care for patients.

Pangaea Data, based in London and San Francisco, uses NVIDIA NeMo Agent toolkit and NIM microservices to close care gaps for hard-to-diagnose diseases. The platform helps discover untreated patients by identifying specific clinical features with AI agents, improving patient outcomes and increasing health equity globally.

European venture capital firms like Sofinnova collaborate with NVIDIA DGX Cloud Lepton to support AI-native startups in healthcare and life sciences. Startups like Cure51 and Sensible Biotechnologies achieve significant speedups and cost savings by leveraging NVIDIA BioNeMo and sovereign AI infrastructure. This initiative empowers early-stage biotech companies to scale into new markets with cutting-edge technology.



Read more at NVIDIA: Leading European Healthcare Companies Innovate With NVIDIA AI